Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New online training could ease bowel troubles after rectal cancer

NCT ID NCT05007015

Symptom relief Sponsor: Jewish General Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether transanal irrigation (using water to flush the bowel) can improve quality of life and reduce bowel symptoms in 66 rectal cancer survivors who have low anterior resection syndrome (LARS). Participants learn the technique through an online platform with virtual nursing support. The goal is to see if this approach is practical and helpful for Canadian patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 66 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2022

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Low anterior resection by a laparoscopic, robotic, transanal total mesorectal excision, or open approach with (or without) creation of a diverting loop ileostomy for the treatment of rectal cancer, advanced adenoma or dysplasia And * have had their ileostomy closed (if applicable) And * completed treatment at least 6 months ago (including ileostomy closure) And * LARS score \> 20 points Exclusion Criteria: * Inability to provide informed consent, including insufficient fluency in English or French. * Inability to access the internet. * Presence of an ostomy at the time of study enrollment. * Active or ongoing treatment for rectal disease. * Anastomotic stricture, sinus, or any other ongoing anastomotic complication. * Current use of TAI under the direction of a clinical team.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Low anterior resection syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Low Anterior Resection Syndrome rectal cancer rectal neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Low anterior resection syndrome Rectal cancer

Contacts and locations

Locations

  • Centre de Recherche du CHU de Québec - Hôpital Saint-François d'Assise

    Québec, Quebec, G1L 3L5, Canada

  • Health Science North

    Greater Sudbury, Ontario, P3E 5J1, Canada

  • Jewish General Hospital

    Montreal, Quebec, H3T 1E2, Canada

  • London Health Science Centre

    London, Ontario, N6A 5W9, Canada

  • McGill University Health Centre

    Montreal, Quebec, Canada

  • Providence Hospital - St. Paul's Hospital

    Vancouver, British Columbia, V6Z 1Y6, Canada

  • University Health Network

    Toronto, Ontario, M5G 2C4, Canada

  • University of British Columbia - Island Health Colorectal Surgery

    Victoria, British Columbia, V8R 6R5, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.